Your browser doesn't support javascript.
loading
Effects of the Antioxidant Quercetin in an Experimental Model of Ulcerative Colitis in Mice.
Kottakis, George; Kambouri, Katerina; Giatromanolaki, Alexandra; Valsami, Georgia; Kostomitsopoulos, Nikolaos; Tsaroucha, Alexandra; Pitiakoudis, Michael.
Affiliation
  • Kottakis G; Department of Experimental Surgery, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
  • Kambouri K; Department of Pediatric Surgery, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
  • Giatromanolaki A; Department of Pathology, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
  • Valsami G; Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15784 Athens, Greece.
  • Kostomitsopoulos N; Biomedical Research Foundation (BRFAA) of the Academy of Athens, Experimental Surgery and Translational Research, 11527 Athens, Greece.
  • Tsaroucha A; Department of Experimental Surgery, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
  • Pitiakoudis M; 2nd Department of General Surgery, University of Thrace, 68100 Alexandroupolis, Greece.
Medicina (Kaunas) ; 59(1)2022 Dec 31.
Article in En | MEDLINE | ID: mdl-36676712
Background and Objectives: Quercetin, a member of the flavanol family found in many fruits, vegetables, leaves and grains has been found to have a wide range of biological effects on human physiology. The aim of this study was to investigate the effects of quercetin, when administered orally in the form of the water-soluble inclusion complex with hydroxypropyl-b-cyclodextrin (Que-HP-ß-CD), in an experimental model of ulcerative colitis in mice. Materials and Methods: Animals received either Dextran Sodium Sulphate (DSS), to induce colitis, + Que-HP-ß-CD (Group A), DSS alone (Group B) or no intervention (control, Group C) for 7 days. All animals were weighed daily, and evaluation of colitis was performed using the Disease Activity Index (DAI). On day 7 a blood sample was taken from all animals, they were then euthanised, the large intestine was measured, and histological and immunochemical analyses were performed. Results: The DAI demonstrated an increase over time for the groups receiving DSS (Groups A and B) compared with the control group (Group C), with a significant degree of protection being observed in the group that also received quercetin (Group A): The DAI over time slope for Group B was higher than that for Group A by 0.26 points/day (95% Cl 0.20−0.33, p < 0.01). Weight calculations and immunohistochemistry results validated the DAI findings. Conclusions: In conclusion, the administration of quercetin in an ulcerative colitis model in mice presents a therapeutic/prophylactic potential that warrants further investigation.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colitis, Ulcerative / Colitis Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Medicina (Kaunas) Journal subject: MEDICINA Year: 2022 Type: Article Affiliation country: Greece

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colitis, Ulcerative / Colitis Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Medicina (Kaunas) Journal subject: MEDICINA Year: 2022 Type: Article Affiliation country: Greece